½ÃÀ庸°í¼
»óÇ°ÄÚµå
1515374
¼¼°èÀÇ ¿µ¾ç À¯ÀüüÇÐ ½ÃÀå : Á¶¼ºº°, ÃÖÁ¾ »ç¿ëÀÚº°, ¿ëµµº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À² ¿¹Ãø(2024-2032³â)Nutritional Genomics Market, By Composition, By End User, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032 |
¿µ¾ç À¯ÀüüÇÐ ½ÃÀå ±Ô¸ð´Â 2023³â 5¾ï 3,456¸¸ ´Þ·¯·Î 2024³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 16.8%·Î È®´ë
¿µ¾ç À¯ÀüüÇÐ ½ÃÀå - ½ÃÀå ¿ªÇÐ
O ¸¸¼ºÁúȯÀÇ ¸¸¿¬ÀÌ ½ÃÀå ¼ö¿ä¸¦ ÃËÁø
¸¸¼º ÁúȯÀÇ ºÎ´ã Áõ°¡´Â ÇâÈÄ ¼ö³â°£ ¿µ¾ç À¯Àüü ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀÌ µÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ´Ü¹éÁúüÇÐ, À¯ÀüüÇÐ, ¸ÞŸº¸·Î¹Í½º¸¦ ºñ·ÔÇÑ ´Ù¾çÇÑ ¿À¹Í½º ±â¼úÀÇ Ãֱ٠ȹ±âÀûÀÎ Áøº¸´Â ¹ÙÀÌ¿ÀÀÎÆ÷¸Åƽ½ºÀÇ Áøº¸¿Í ÇÔ²² ¿¬±¸ÀÚµéÀÌ Æ¯Á¤ ´Ü¹éÁú °æ·Î¿¡ ±âÃÊÇÏ¿© Áúº´À» È®ÀÎÇÒ ¼ö ÀÖ°Ô Çß½À´Ï´Ù. ¿µ¾ç À¯ÀüüÇп¡¼ÀÇ ÀÌ·¯ÇÑ Áö°ßÀº ´ç´¢º´, ¾Ï, ºñ¸¸ µî ¿µ¾çÀû ¿ä¼Ò¸¦ Æ÷ÇÔÇÑ Áúȯ¿¡ ´ëÇÑ ½Ä»ç °³ÀÔ¹ýÀÇ °³¹ß¿¡ È°¿ëµÇ°í ÀÖÀ¸¸ç, ¼¼°è ½ÃÀåÀÇ È®´ë¿¡ Å©°Ô ±â¿©ÇÏ°í ÀÖ½À´Ï´Ù. ±×·¯³ª À¯ÀüÀÚ ¿¬±¸¿Í °Ë»ç¸¦ µÑ·¯½Ñ Á¤ºÎÀÇ ¾ö°ÝÇÑ ±ÔÁ¦´Â ¿µ¾ç À¯ÀüüÇÐ °Ë»ç ¼ö¿ä¸¦ ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¬¹æÁ¤ºÎ, ÁÖÁ¤ºÎ, Áö¹æÀÚÄ¡´Üü¿¡ ÀÇÇÑ »õ·Î¿î ±ÔÁ¦´Â ÀÌ·¯ÇÑ È°µ¿À» Á¦ÇÑÇϰųª Á¦ÇÑÇÒ ¼ö Àֱ⠶§¹®¿¡ À¯ÀüÀÚ ¿¬±¸ ¹× °Ë»ç¸¦ ½Ç½ÃÇϴµ¥ ÀÖ¾î¼ °úÁ¦°¡ µË´Ï´Ù. ¼ÒºñÀÚ Á÷Á¢ ÆǸÅ(DTC) °Ë»ç¿¡ ´ëÇÑ ÀÏ°ü¼º ¾ø´Â ±ÔÁ¦´Â ½ÃÀåÀ» ´õ¿í º¹ÀâÇÏ°Ô ¸¸µì´Ï´Ù. »õ·Î¿î °Ë»ç¸¦ ½ÃÀÛÇϱâ À§ÇØ Á¤ºÎÀÇ ½ÂÀÎÀ» ¾ò´Â °Íµµ ¿î¿µ ºñ¿ëÀ» Áõ°¡½ÃÅ°°í °Ë»ç ´É·ÂÀ» Á¦ÇÑÇÏ¸ç ¿µ¾ç À¯Àüü »ê¾÷ÀÇ ¼ºÀåÀ» Á÷Á¢ ¹æÇØÇÕ´Ï´Ù. ¿µ¾ç À¯ÀüüÇд ¿µ¾çÇп¡ ³Î¸® Àû¿ëµÇ¸ç °³ÀÎ °íÀ¯ÀÇ À¯ÀüÀÚ ±¸¼ºÀ» ±â¹ÝÀ¸·Î ¸ÂÃãÇü ¿µ¾ç Ãßõ ½ÄÇ°, ±â´É¼º ½ÄÇ° ¹× º¸ÃæÁ¦¸¦ °³¹ßÇÕ´Ï´Ù. DNA¸¦ Á¶»çÇÔÀ¸·Î½á, ¿¬±¸ÀÚ´Â ¿µ¾ç¼ÒÀÇ ¹ÝÀÀ¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â À¯ÀüÀû º¯À̸¦ È®ÀÎÇÏ°í °Ç°°ú À£ºùÀÇ Çâ»óÀ» À§ÇØ Àû±ØÀûÀÎ °³ÀÔÃ¥À» ³»³õÀ» ¼ö ÀÖ½À´Ï´Ù. ¿µ¾ç À¯Àüü ½ÃÀåÀÌ ¹ßÀüÇÔ¿¡ µû¶ó ÃÖÀûÀÇ °Ç°°ú À£ºùÀ» ´Þ¼ºÇϱâ À§ÇÑ µµ±¸¸¦ Á¦°øÇÏ´Â ÀáÀç·ÂÀÌ È®´ëµÇ°í ´õ ³ªÀº ½Ä»ýÈ° ±ÇÀå »çÇ×ÀÌ Á¦°øµË´Ï´Ù. ¿µ¾ç À¯ÀüüÇÐÀÇ È¿À²ÀûÀÎ ÀÌÇàÀ» À§Çؼ´Â ¿À¹Í½º ±â¼úÀÇ ÅëÇÕÀû ÀÌ¿ë, ºñ¿ë È¿À²ÀûÀÎ ºÐ¼®¹ýÀÇ °³¹ß, À±¸®Àû ¹®Á¦¿¡ ´ëÇÑ °í·Á°¡ ÇÊ¿äÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀÎÀº ¿µ¾ç À¯Àüü ½ÃÀå ¿¹Ãø¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¿µ¾ç À¯Àüü ½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®
¸®¼Ä¡ ¾Ö³Î¸®½ºÆ®ÀÇ ºÐ¼®¿¡ µû¸£¸é ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2024-2032³â)¿¡ ¾à 16.8%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¸Å³â ¼ºÀåÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.
½ÃÀå ¼¼ºÐÈ´Â ½Ã¾à ¹× Å°Æ®°¡ 2023³â¿¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
¿ëµµº°·Î´Â 2023³â¿¡´Â ºñ¸¸ÀÌ ÁÖ¿ä À¯ÇüÀ̾ú½À´Ï´Ù.
Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2023³â ¼öÀÍÀ¸·Î À̲ø¾ú½À´Ï´Ù.
¼¼°èÀÇ ¿µ¾ç À¯Àüü ½ÃÀåÀº ±¸¼º, ÃÖÁ¾ »ç¿ëÀÚ, ¾ÖÇø®ÄÉÀÌ¼Ç ¹× Áö¿ª¿¡ µû¶ó ¼¼ºÐȵ˴ϴÙ.
½ÃÀåÀº ±¸¼º¿¡ µû¶ó µÎ °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. ½Ã¾à, Å°Æ® ¹× ¼ºñ½º ½Ã¾à ¹× Å°Æ® ºÎ¹®Àº 2023³â ¿µ¾ç À¯Àüü ½ÃÀå¿¡¼ °¡Àå ³ôÀº Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀÌ ¼ºÀåÀÇ ¿øµ¿·ÂÀ̵Ǵ °ÍÀº ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í, ½Ä»ýÈ°ÀÇ º¯È³ª °Ç°¿¡ ÇØ·Î¿î »ýÈ° ½À°ü¿¡ ±âÀÎÇÏ´Â °æ¿ì°¡ ¸¹Àº ÀÌ·¯ÇÑ ÁúȯÀ¸·ÎºÎÅÍ ¸öÀ» ÁöÅ°±â À§ÇÑ ½Ä»ýÈ°ÀÇ °³º°È ÀÔ´Ï´Ù. ÃÖ±Ù ¸¹Àº ±â¾÷µéÀÌ ÀÎÅͳÝÀ» ÅëÇØ DNA °Ë»ç Å°Æ®¸¦ ¼ÒºñÀÚ¿¡°Ô Á÷Á¢ ÆǸÅ(DTC)ÇÏ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ, ¿ø°Ý ÀÇ·á ¼ºñ½ºÀÇ Ã¤ÅÃÀº ¿µ¾ç À¯Àüü »ê¾÷¿¡¼ ½Ã¾à ¹× Å°Æ® ¼ö¿ä¸¦ ÃËÁøÇÏ°í ÀÖ½À´Ï´Ù.
½ÃÀåÀº ¾ÖÇø®ÄÉÀ̼ǿ¡ µû¶ó ³× °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù : ´ç´¢º´, ½ÉÇ÷°ü Áúȯ, ¾Ï ¿¬±¸, ºñ¸¸. ÀÀ¿ë ºÐ¾ßº°·Î ºñ¸¸ ºÐ¾ß´Â 2022³â ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù. °úüÁß°ú ºñ¸¸ÀÇ À¯º´·üÀº ÃÖ±Ù ±ØÀûÀ¸·Î »ó½ÂÇÏ°í ÀÖ½À´Ï´Ù. ¼¼°è ºñ¸¸ ¿¬¸ÍÀÇ 2023³âÆÇ Atlas projects´Â ÇâÈÄ 12³â À̳»¿¡ ¼¼°è Àα¸ÀÇ Àý¹Ý(51%)À» ÃÊ°úÇÏ´Â 40¾ï ¸íÀÌ °úüÁß ¶Ç´Â ºñ¸¸À¸·Î ºÐ·ùµÉ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ »ó´çÇÑ Áõ°¡´Â Å« °æÁ¦Àû ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±× °á°ú, °úüÁß Àα¸ Áõ°¡´Â ÇâÈÄ ¿µ¾ç À¯ÀüüÇÐ °Ë»ç ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¿µ¾ç À¯Àüü ½ÃÀå - Áö¸®Àû ÅëÂû
Áö¸®ÀûÀ¸·Î, ÀÌ ½ÃÀåÀº ºÏ¹Ì, ¶óƾ¾Æ¸Þ¸®Ä«, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«À¸·Î ÆÛÁ® ÀÖ½À´Ï´Ù. Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2023³â ¼¼°è ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù. ºÏ¹Ì¿¡¼´Â ¸¸¼º °Ç° »óÅÂÀÇ ºÎ´ãÀÌ Áõ°¡ÇÏ°í Àֱ⠶§¹®¿¡ ¿µ¾ç À¯ÀüüÇÐ ¼Ö·ç¼Ç ¼ö¿ä°¡ ±ÞÁõÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹Ì±¹ Áúº´¿¹¹æ°ü¸®¼¾ÅÍ(CDC)ÀÇ µ¥ÀÌÅͷκÎÅÍ 2022³â ½ÃÁ¡¿¡¼ ¹Ì±¹ 50°³ ÁÖ ¸ðµÎ°¡ ºñ¸¸·ü 20%¸¦ ³Ñ¾î 17°³ ÁÖ°¡ 35% ÀÌ»óÀÇ ¿ì·ÁÇØ¾ß ÇÒ °æÇâÀÌ ¹àÇôÁ³½À´Ï´Ù. ¶ÇÇÑ, ºÏ¹Ì ±â¾÷Àº °í°´¿¡°Ô À¯ÀüÀÚ º¸°í¼¸¦ Á¦°øÇÔÀ¸·Î½á ¿µ¾ç À¯ÀüÇÐ Á¶»ç¿¡ Àû±ØÀûÀ¸·Î ±â¿©ÇÏ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ÀÌ Áö¿ªÀÇ À¯·Â ±â¾÷ÀÎ 23andMe´Â 2021³â¿¡ 67°³ÀÇ ´ÙÀ¯ÀüÀÚ À§Çè Á¡¼ö(PRS) º¸°í¼¸¦ Á¦°øÇϸç, ±× Áß 37°³´Â °¡ÀÔÀÚ¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀÇ ÁÖ¿ä ¿µ¾ç À¯Àüü ±â¾÷ÀÇ °ß°íÇÑ Á¸Àç´Â ¿µ¾ç À¯Àüü °Ë»ç ½ÃÀå¿¡ Å« ¼ºÀå ±âȸ¸¦ âÃâÇϴ ż¼¸¦ °®Ãß°í ÀÖ½À´Ï´Ù.
¿µ¾ç À¯ÀüüÇÐ ½ÃÀå¿¡¼ ±â¾÷Àº °æÀï·ÂÀ» À¯ÁöÇϱâ À§ÇØ ´Ù¾çÇÑ Àü·«Àû Á¦ÈÞ¿Í ÆÄÆ®³Ê½ÊÀ» È°¿ëÇÕ´Ï´Ù. ¿¬±¸±â°ü, ÇコÄɾî Á¦°ø¾÷ü, ½ÄÇ°Á¦Á¶¾÷ü¿Í Á¦ÈÞÇÔÀ¸·Î½á, ÀÌµé ±â¾÷Àº °³º°È ¿µ¾çÇÐÀÇ °úÇÐÀû Áøº¸¿Í »õ·Î¿î µ¿ÇâÀÇ ÃÖÀü¼±¿¡ ¼¼ °è¼ÓÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¦ÈÞ¸¦ ÅëÇØ ±¤¹üÀ§ÇÑ µ¥ÀÌÅͺ£À̽º, ÃÖ÷´Ü ±â¼ú, À¯ÀüüÇÐ ¹× ¿µ¾ç °úÇÐÀÇ Àü¹®ÀûÀÎ Àü¹® Áö½Ä¿¡ ´ëÇÑ ¾×¼¼½º¸¦ °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ¾ç»çÀÇ °Á¡À» °áÇÕÇÏ¿© ±â¾÷Àº °³º° À¯Àü ÇÁ·ÎÆÄÀÏ¿¡ ¸Â´Â ¸ÂÃãÇü ¿µ¾ç Á¦Ç°°ú ¼ºñ½º¸¦ °³¹ßÇÏ¿© °Ç° ¼º°ú¿Í À£ºù ¸ñÇ¥¸¦ ÃÖÀûÈÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àü·«Àû Á¦ÈÞ´Â ±â¾÷ÀÌ ½ÃÀå¿¡¼ÀÇ ÁöÀ§¸¦ °ÈÇÏ°í, Á¦Ç° Á¦°øÀ» È®´ëÇÏ°í, °³º°È ¿µ¾çÇÐÀÇ Çõ½ÅÀ» ÃßÁøÇÏ´Â µ¥ µµ¿òÀÌ µÇ°í, ¿¹¹æ ÇコÄɾîÀÇ ¹Ì·¡¸¦ Çü¼ºÇÏ°Ô µË´Ï´Ù. ÁÖ¿ä ½ÃÀå ±â¾÷Àº Á¾Á¾ Á¦ÈÞ, Àμö, Á¦Ç° Ãâ½Ã µîÀÇ Àü·«À» äÅÃÇÕ´Ï´Ù.
Nutritional Genomics Market size was valued at USD 534.56 Million in 2023, expanding at a CAGR of 16.8% from 2024 to 2032.
Nutritional Genomics is a field of science that explores the intricate relationship between nutrients and gene expression. Examining how dietary components influence the activation or silencing of genes, offers a genetic perspective on how food choices can tip the scales towards health or disease. This burgeoning field holds immense promise for the development of personalized nutrition plans and customized diets. The rising demand for personalized approaches to nutrition fuels the growth of the Nutritional Genomics testing market. Nutrigenetics, a complementary area of study, also contributes to the creation of personalized diets and supplements. Through analysis of an individual's DNA, healthcare professionals can identify genetic variations that impact nutrient absorption or metabolism. This allows for the development of targeted supplements, such as a specially formulated B12 supplement for individuals with a genetic variant hindering its absorption.
Nutritional Genomics Market- Market Dynamics
O Increasing prevalence of chronic diseases to propel market demand
The growing burden of chronic illnesses is anticipated to be a key driver of the Nutritional Genomics market in the coming years. Recent breakthroughs in various omics technologies, including proteomics, genomics, and metabolomics, coupled with advancements in bioinformatics, have enabled researchers to identify diseases based on specific protein pathways. These findings in Nutritional Genomics are being leveraged to develop dietary interventions for diseases with a nutritional component, such as diabetes, cancer, and obesity, thereby contributing significantly to the global market expansion. However, stringent government regulations surrounding genetic research and testing could potentially hinder the demand for Nutritional Genomics testing. New regulations from federal, state, and local governments create challenges for conducting genetic research and testing, as they may limit or restrict these activities. Inconsistent regulations related to direct-to-consumer (DTC) testing further complicate the market. Obtaining government approvals for new test launches also increases operational costs and restricts testing capabilities, directly hampering the growth of the Nutritional Genomics industry. Nutritional Genomics is widely applied in nutrition to develop tailor-made dietary recommendations, functional foods, and supplements based on an individual's unique genetic makeup. By examining DNA, researchers can identify genetic variations that affect nutrient responses and create targeted interventions for improved health and wellbeing. As the Nutritional Genomics market evolves, its potential to provide tools for achieving optimal health and wellness will expand, offering better dietary recommendations. Efficient implementation of Nutritional Genomics requires the integrated use of omics techniques, the development of cost-effective analytical methods, and consideration of ethical issues. These factors are expected to positively impact the Nutritional Genomics market forecast.
Nutritional Genomics Market- Key Insights
v As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 16.8% over the forecast period (2024-2032)
v Based on Composition segmentation, reagents and kits were predicted to show maximum market share in the year 2023
v Based on Application segmentation, obesity was the leading type in 2023
v Based on region, North America was the leading revenue generator in 2023
The Global Nutritional Genomics Market is segmented based on Composition, End User, Application, and Region.
The market is divided into two categories based on Composition: Reagents and Kits and Services The reagents and kits segment held the highest Nutritional Genomics market share in 2023. This growth is driven by the increasing prevalence of chronic diseases and the personalization of diets to protect against these conditions, which often result from dietary changes or unhealthy lifestyles. In recent years, numerous companies have begun selling DNA testing kits directly to consumers (DTC) via the Internet. Additionally, the adoption of telehealth services is also driving demand for reagents and kits in the Nutritional Genomics industry.
The market is divided into four categories based on Application: Diabetes, Cardiovascular Diseases, Cancer Research and Obesity. By application, the obesity segment dominated the market in 2022. The prevalence of overweight and obesity has risen dramatically in recent years. The World Obesity Federation's 2023 Atlas projects that within the next twelve years, over half (51%) of the world's population, exceeding 4 billion individuals will be classified as overweight or obese. This substantial increase is anticipated to have a significant economic impact. Consequently, the increasing overweight population is expected to boost the growth of the Nutritional Genomics testing market in the future.
Nutritional Genomics Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. By region, North America dominated the global market in 2023. North America is expected to witness a surge in demand for Nutritional Genomics solutions due to the increasing burden of chronic health conditions. Data from the Centers for Disease Control and Prevention (CDC) reveals a concerning trend, with all 50 U.S. states exceeding a 20% obesity rate as of 2022, with 17 exceeding 35%. Furthermore, North American companies are actively contributing to Nutritional Genomics research by providing genetic reports to their customers. For example, 23andMe, a prominent player in the region, offered 67 polygenic risk score (PRS) reports in 2021, with 37 available exclusively to their subscribers. This robust presence of key Nutritional Genomics companies within the region is poised to create substantial growth opportunities in the Nutritional Genomics testing market.
In the Nutritional Genomics market, companies leverage various strategic collaborations and partnerships to maintain their competitive edge. By teaming up with research institutions, healthcare providers, and food manufacturers, these firms stay at the forefront of scientific advancements and emerging trends in personalized nutrition. Such collaborations enable access to extensive databases, cutting-edge technologies, and specialized expertise in genomics and nutrition science. By combining their strengths, companies can develop tailored nutritional products and services that cater to individual genetic profiles, optimizing health outcomes and wellness goals. These strategic alliances help companies strengthen their market position, expand their product offerings, and drive innovation in personalized nutrition, thereby shaping the future of preventive healthcare. Major market players often adopt strategies like partnerships, acquisitions, and product launches.
v In May 2023, Xcode Life launched a comprehensive Gene Nutrition test, that covers nearly 50 aspects of nutrition, including macronutrient breakdown according to genotype, vitamin and mineral deficiency risks, eating behaviors, weight management, taste preferences, diet responses, food sensitivities.
GLOBAL NUTRITIONAL GENOMICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT
O Ancestry
O Nutrigenomix
O 23andMe Inc.
O DNAfit
O GX Sciences Inc.
O Xcode Life
O Koninklijke
O DSM N.V. (Royal DSM)
O BASF SE
O Danone S.A.
O The Gene Box
O Others